Publications
5808 Results
- Journal / Conference
- Leukemia & Lymphoma Oct;57(10):2359-2369; 2016 Jan 12:1-11 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID26758422
- PMC
- PMC5140034
- Study Number(s)
- S0520
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive b-cell lymphomas: SWOG S0520
- Journal / Conference
- Biology of Blood and Marrow Transplantation Aug;22(8):1440-1448;2016 Apr 23 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27118571
- PMC
- PMC4949103
Reduced intensity conditioning with high dose RTX yields excellent outcomes after allogeneic hematopoietic cell transplantation for relapsed follicular lymphoma: a phase II multicenter trial from the blood and marrow transplant network
- Journal / Conference
- JAMA Oncology, Jan 1;2(1):137-139
- Year
- 2016
- Research Committee(s)
- Cancer Survivorship
- PMID
- PMID26468994
- PMC
- PMC4824189
- Study Number(s)
- S0316
Patient income level and cancer clinical trial participation in a prospective survey study [Research Letter]
- Journal / Conference
- British Journal of Haematology Sep;174(5):686-691; 2016 Apr 13 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27072903
- PMC
- PMC5125530
- Study Number(s)
- S9704
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: Subset analysis of randomized trial intergroup S9704
- Journal / Conference
- British Journal of Urology International, Mar;117(3):500-506
- Year
- 2016
- Research Committee(s)
- Cancer Control
- PMID
- PMID26269564
- PMC
- PMC4826049
- Study Number(s)
- SWOG-9217
Non-steroidal anti-inflammatory drug use not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Blood Cancer Journal 2016 Mar 25;6:e410. doi: 10.1038/bcj.2016.19
- Year
- 2016
- Research Committee(s)
- Myeloma
- PMID
- PMID27015287
- PMC
- PMC4817101
- Study Number(s)
- S0120
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention Mar;25(3):463-469
- Year
- 2016
- Research Committee(s)
- Cancer Control
- PMID
- PMID26715424
- PMC
- PMC4779655
- Study Number(s)
- SWOG-9217
Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention Jul;25(7):1050-1058
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27197287
- PMC
- PMC5086806
- Study Number(s)
- S0000
Selenium- or vitamin E-related gene variants, interaction with supplementation, and risk of high-grade prostate cancer in SELECT
- Journal / Conference
- Cancer Aug 1;122(15):2332-2340; 2016 May 10 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Cancer Control
- PMID
- PMID27164191
- PMC
- PMC4956504
- Study Number(s)
- SWOG-9217
Association of androgen metabolism gene polymorphisms with steroid hormone concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- American Journal of Clinical Oncology 2016 Sep 15 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Brain
- PMID
- PMID27635620
- PMC
- PMC5352534
- Study Number(s)
- E4397